Top compounds associated with response to SAMD4B


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.089 0.01
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.18 0.01
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.18 0.01
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.089 0.01
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.072 0.02
Download CSV